
What you should know about the 3M spin off
US multinational conglomerate 3M is listing its healthcare business in a bid to streamline revenue and boost investor income. Find out everything we know so far about the 3M spin off.
Share this:
US multinational conglomerate 3M is listing its healthcare business in a bid to streamline revenue and boost investor income. Find out everything we know so far about the 3M spin off.
3M spin off explained
3M Co (MMM) announced on July 23 that it would be spinning off its healthcare business into a new listed company. This comes as a wave of other US companies – especially in the healthcare sector – have streamlined their businesses and boosted investor returns via spin offs and demergers.
3M as a whole has underperformed in recent years due to supply chain disruption, currency fluctuations and the rising cost of living. So, the spin off is an attempt to boost 3M’s value, and allow both the new business and the old to build on current revenues, and focus their resources more efficiently.
3M will retain a stake worth 19.9% in the medical supplies business but sell that holding off over time.
3M spin off date
There’s no date for the 3M spin off yet, but the transaction is expected to be completed by the end of 2023, depending on when it’s approved by regulators.
How much will the new company be worth?
3M’s health business could be worth as much as $45 billion by the company’s estimates. It had approximately $9 billion in annual sales according to the company’s reports, which accounts for almost a quarter of the company’s total revenue.
What will happen to 3M shares after the split?
3M shares have already seen a boost following the announcement, and the company will be hoping this marks the end of the downtrend it’s seen so far in 2022. The company’s share price was down 19.4% in the year to date, sitting at 134.12, but on the day of the announcement shares jumped up 4.9% to a closing price of 140.7.
3M will also be hoping that the spin off will draw a line under the litigation proceedings that have brought the company’s share price down over the last year. The healthcare giant has sought protection for the unit that makes earplugs for the military after over 290,000 military members said they suffered hearing damage as a result of the company’s products.
How to trade 3M shares with City Index
You can speculate on whether 3M shares will rise or fall in the run up to the demerger with City Index in just four easy steps:
- Open a City Index account, or log in if you’re already a customer
- Search for ‘3M’ in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Alternatively, you can try out share trading risk free by signing up for our demo trading account.
Related tags:
Latest market news
View more newsThe complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

S&P 500, Nasdaq, Dow Forecast: Rising Yields Test Rally Ahead of Nvidia, Fed 8 22 2026
S&P 500, Nasdaq and Dow test key technical levels as momentum fades, raising the risk of a deeper correction heading into a pivotal week.

SP 500 Forecast SPX remains cautious as risk appetite weakens
It has not been an easy stretch for the S&P 500. Over the last 5 trading sessions, the index has accumulated a decline of nearly -0.9%, while the broader outlook continues to show a phase of neutrality and indecision.

Magnificent Seven Earnings Preview: Can Big Tech Reclaim AI Leadership?
The Magnificent Seven enter earnings with far more divided performance than in previous years, as investors increasingly distinguish between companies supplying the AI buildout and those funding it - what does that mean heading into earnings season?
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.







